» Articles » PMID: 9694051

Undifferentiated Connective Tissue Disease: Natural History and Evolution into Definite CTD Assessed in 84 Patients Initially Diagnosed As Early UCTD

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 1998 Aug 7
PMID 9694051
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Connective tissue diseases (CTDs) are chronic multisystemic inflammatory disorders whose indicative signs or symptoms have a high sensitivity but poor specificity in predicting the evolution into a given CTD. We have analysed 84 consecutive patients initially diagnosed as having an early undifferentiated CTD (early UCTD) with the aim of verifying the evolution into one definite CTD and of evaluating the predictive value of clinical and laboratory parameters. During a 5-year study period, 33 patients developed signs of a full-blown CTD; the highest probability of evolution was in the first 48 months after the onset. Multivariate analysis allowed us to select those variables correlating with evolution into a particular CTD, such as sclerodactyly and oesophageal dysfunction for systemic sclerosis, xerostomia and anti-nuclear antibodies (SS-A pattern) for Sjögren's syndrome, and fever and anti-DNA antibodies for systemic lupus erythematosus. Furthermore, we assessed the prevalence of various clinical and laboratory manifestations, complications and prognosis of those patients diagnosed after a 5-year disease duration period as having a UCTD. In our series, major organs such as the kidney or heart seem to be spared, whereas we detected a relatively high prevalence of endocrine disease of autoimmune origin.

Citing Articles

Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in a cohort of Colombian population.

Celis-Andrade M, Rojas M, Rodriguez Y, Calderon J, Rodriguez-Jimenez M, Monsalve D Clin Rheumatol. 2024; 43(11):3313-3322.

PMID: 39243279 PMC: 11489229. DOI: 10.1007/s10067-024-07108-x.


The Multiple Faces of Systemic Lupus Erythematosus: Pearls and Pitfalls for Diagnosis.

Kapsala N, Nikolopoulos D, Fanouriakis A Mediterr J Rheumatol. 2024; 35(Suppl 2):319-327.

PMID: 39193185 PMC: 11345601. DOI: 10.31138/mjr.130124.ppa.


A Rare Case of Polymyositis and Systemic Sclerosis Overlap Syndrome: Diagnosis and Treatment.

Uddin M, Vempati R, Bhavanam S, Parven P, Khotele C, Chitturi R Cureus. 2023; 15(3):e36434.

PMID: 37090317 PMC: 10115541. DOI: 10.7759/cureus.36434.


Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development.

Choi M, Costenbader K Front Immunol. 2022; 13:890522.

PMID: 35720390 PMC: 9203849. DOI: 10.3389/fimmu.2022.890522.


Differentiating between UCTD and early-stage SLE: from definitions to clinical approach.

Sciascia S, Roccatello D, Radin M, Parodis I, Yazdany J, Pons-Estel G Nat Rev Rheumatol. 2021; 18(1):9-21.

PMID: 34764455 DOI: 10.1038/s41584-021-00710-2.


References
1.
Alarcon-Segovia D, Cardiel M . Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol. 1989; 16(3):328-34. View

2.
Bohan A, Peter J . Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975; 292(7):344-7. DOI: 10.1056/NEJM197502132920706. View

3.
Ganczarczyk L, Urowitz M, Gladman D . "Latent lupus". J Rheumatol. 1989; 16(4):475-8. View

4.
Gerbracht D, Steen V, Ziegler G, Medsger Jr T, Rodnan G . Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum. 1985; 28(1):87-92. DOI: 10.1002/art.1780280114. View

5.
Kallenberg C . Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions. Curr Opin Rheumatol. 1995; 7(6):568-73. DOI: 10.1097/00002281-199511000-00017. View